Custopharm Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CUSTOPHARM INC, and what generic and branded alternatives to CUSTOPHARM INC drugs are available?
CUSTOPHARM INC has two approved drugs.
Summary for Custopharm Inc
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Custopharm Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Custopharm Inc | CALCITONIN-SALMON | calcitonin salmon | INJECTABLE;INJECTION | 212416-001 | May 14, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Custopharm Inc | GANCICLOVIR SODIUM | ganciclovir sodium | INJECTABLE;INJECTION | 212001-001 | Jun 20, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
